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Infectious bursal disease virus (IBDV) is the major viral pathogen in the poultry industry. Live attenuated
serotype 1 vaccine strains are commonly used to protect susceptible chickens during their first 6 weeks of life.
Wild-type serotype 1 IBDV strains are highly pathogenic only in chickens, whereas serotype 2 strains are
apathogenic in chickens and other birds. Here we describe the replacement of the genomic double-stranded
RNA (dsRNA) encoding the N- or C-terminal part of VP3 of serotype 1 very virulent IBDV (vvIBDV) (isolate
D6948) with the corresponding part of serotype 2 (isolate TY89) genomic dsRNA. The modified virus contain-
ing the C-terminal part of serotype 2 VP3 significantly reduced the virulence in specific-pathogen-free chickens,
without affecting the distinct bursa tropism of serotype 1 IBDV strains. Furthermore, by using serotype-specific
antibodies we were able to distinguish bursas infected with wild-type vvIBDV from bursas infected with the
modified vvIBDV. We are currently evaluating the potential of this recombinant strain as an attenuated live
vaccine that induces a unique serological response (i.e., an IBDV marker vaccine).
The relatively unknown infectious bursal disease virus
(IBDV) is currently responsible for a huge economic impact on
the worldwide poultry industry (33). IBDV, an avibirnavirus, is
the causative agent of a highly contagious disease among chick-
ens known as Gumboro disease (13). The genome of IBDV
consists of two segments of double-stranded RNA (dsRNA)
(16). The largest dsRNA segment (the A segment, 3,260 bp)
contains two partly overlapping open reading frames (ORFs).
The first, smaller ORF encodes the nonstructural viral protein
5 (VP5) (145 to 149 amino acids, 17 kDa). The second ORF
encodes a polyprotein (1.012 amino acids, 110 kDa) that is
autocatalytically cleaved to yield the viral proteins pVP2 (also
known as VPX) (48 kDa), VP4 (29 kDa), and VP3 (33 kDa).
During in vivo virus maturation, pVP2 is processed into VP2
(41 to 38 kDa), probably resulting from site-specific cleavage of
pVP2 by a host cell-encoded protease (23). The smaller B
segment (2,827 bp) contains one large ORF, encoding VP1
(877 to 881 amino acids, 91 kDa). VP1 is the RNA-dependent
RNA polymerase and is present both in its free form and
covalently linked to the 5 ends of the genomic RNA segments
(viral protein genome linked [VPg]) (14). In vivo expression of
the polyprotein (VP2-VP4-VP3) results in the formation of
virus-like particles, consisting of VP2 and VP3, which have the
same dimension as mature virions (60 nm). This indicates that
neither VP1 nor viral dsRNA is essential for the formation of
the viral capsid (18).
Two different serotypes of IBDV (serotypes 1 and 2) have
been described (27). The pathogenic wild-type serotype 1
IBDV isolates specifically infect developing B-lymphoid cells
in the bursa of Fabricius. Serotype 1 isolates are subdivided
into classical, antigenic variant, and very virulent isolates. An-
tigenic variant IBDV isolates appeared to have single amino
acid changes in a specific region of the VP2 protein (the hy-
pervariable region) that lead to a partial change in antigenicity
(31). Very virulent IBDV (vvIBDV) isolates, which were first
isolated in Europe, have the same antigenic structure as clas-
sical strains but have an increased virulence (12). Amino acid
differences between viral proteins of vvIBDV and classical
IBDV isolates are scattered throughout all viral proteins, al-
though most of them are found in the hypervariable region of
VP2 (10). Specific mutations in VP2 result both in a change of
cell tropism (28) and in attenuation (36). Although VP2 is a
key factor for virulence, we have recently shown that it is not
the sole determinant for the very virulent phenotype (4).
Unlike serotype 1 isolates, wild-type serotype 2 isolates do
not have a specific B-lymphoid cell tropism. Serotype 2 isolates
are able to replicate naturally in different tissues of birds and
can even be propagated on cell lines. Serotype 2 isolates, usu-
ally recovered from turkeys, are apathogenic in turkeys (21)
and in chickens (20). Conformation-dependent, virus-neutral-
izing epitopes of both serotype 1 and 2 isolates are present in
the capsid protein VP2. The other abundant viral capsid pro-
tein (VP3) does not contain virus-neutralizing epitopes, al-
though a rapid immune response to linear VP3 epitopes is
found after both vaccination and infection (17). Both group-
and serotype-specific epitopes have been described for VP3
(25, 29, 34).
A common way of producing IBDV vaccines is adaptation of
wild-type virus by propagation in chicken embryos or in cell
culture with primary chicken embryo cells or cell lines of either
avian or mammalian origin. Adapted wild-type IBDV always
has reduced virulence (attenuation) (35, 37). Differentiation
between live IBDV vaccines and field IBDV isolates recovered
during field outbreaks is difficult and laborious, as the genetic
structure of the IBDV isolate in question has to be determined.
This is either done by sequence analysis (38) or restriction
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fragment length polymorphism (22) of the cDNA. In our
search for an live IBDV vaccine that can easily be distin-
guished from IBDV field isolates, we recently replaced the
complete VP3 protein or the N- or C-terminal part of the VP3
protein of an attenuated IBDV isolate (CEF94) with the cor-
responding part of a serotype 2 isolate (TY89). Analysis of
these rescued serotype 1 IBDV recombinants showed that this
chimeric strain has a slightly reduced release of progeny virus
when grown on QM5 cells, while the final titer was similar to
that of unchanged CEF94 (6). The yield of the mosaic virus in
which either the complete VP3 or the N-terminal part of VP3
was replaced was reduced (final titers were about 10-fold
lower) compared to that of unmodified CEF94, indicating a
more severe effect on replication due to the exchange of the
N-terminal part of VP3.
In this paper we describe the replacement of the genomic
RNA encoding the C-terminal part of VP3 of vvIBDV (isolate
D6948) with the corresponding part of serotype 2 (isolate
TY89) genomic RNA. Compared to unmodified vvIBDV, this
modified vvIBDV strain significantly reduces the mortality and
morbidity rates of specific-pathogen-free (SPF) chickens. Fur-
thermore, by using serotype-specific antibodies we were able to
distinguish between bursas infected with wild-type vvIBDV
and bursas infected with the modified vvIBDV.
MATERIALS AND METHODS
Viruses, cells, and antibodies. The classical IBDV isolate CEF94 is a deriva-
tive of PV1 that is able to replicate in non-B-lymphoid cells (5). The D6948 strain
is a very virulent field isolate (Poultry Health Service, Doorn, The Netherlands;
1989) that grows only in primary B-lymphoid cells (4). IBDV strain TY89 is the
prototype serotype II IBDV strain (27) and is able to grow naturally on avian-
derived fibroblast cell lines such as QM5. Recombinant fowlpox virus containing
the T7 polymerase gene (FP-T7) (9) was generously provided by M. Skinner
(Compton Laboratory, Berks, United Kingdom). QM5 cells (1) were maintained
by using QT35 medium (Gibco/BRL) supplemented with 5% fetal calf serum and
2% antibiotic solution (4) (QM5 medium). Primary bursa cells were isolated
from 14-day-old SPF chicken embryos and were maintained in Eagle’s modified
minimal essential medium supplemented with 15% fetal calf serum, 0.125%
lactoalbumin hydrolysate, and 1,000 U of penicillin and 1 mg of streptomycin per
ml. The VP3-specific monoclonal antibodies (MAb) B10A (25), IVS1 (25), VII S2
(25), and I/G4 S1 (29) were kindly given to us by H. Mu¨ller, University of Leipzig
(Leipzig, Germany), while MAb 9.7 was prepared in our laboratory by using
purified CEF94 as an antigen (6).
Construction of chimeric VP3 cDNAs. The construction of hybrid CEF94 and
TY89 plasmids has been described before (6). To construct plasmid pHB60-
s2VP3N, we generated five different PCR fragments, using Pwo polymerase in 20
reaction cycles. PCR-1N was generated by using pHB-60 as the template and
oligonucleotides AC3 (GGTAGCCACA TGTGACAG) and HY3MR (CCAG
TCCCGC GGATTGTGAGG) at 56°C, yielding a 1,614-bp fragment (nucleo-
tides [nt] 731 to 2346). PCR-2N was generated by using pHB36-s2VPN as the
template and oligonucleotides HY3P (AACGTTTTCC TCACAATCCG CGG
GACTGGG) and M13F-17 (GTAAAACGAC GGCCAGT) at 56°C, yielding a
1,251-bp fragment (nt 2318 to 3566). PCR-3N was generated by using gel-
purified PCR-1N and PCR-2N fragments as the template and oligonucleotides
AC4 (ACCCAGCCAA TCACATCC) and AGTM (GAGACTCCCA GGTAC
CTCAC TC) at 54°C, yielding a 2,151-bp fragment (nt 1057 to 3208), which was
subsequently digested with ScaI (nt 2799), yielding PCR-3sN. PCR-4N was
generated by using pHB-60 as the template and oligonucleotides AC9 (CTCA
AAGAAG ATGGAGACC) and M13F-24 (CGCCAGGGTT TTCCCAGTCA
CGAC) at 54°C, yielding an 869-bp fragment (nt 2727 to 3593). PCR-5 was
generated by using gel-purified PCR-3sN and PCR-4 fragments as the template
and oligonucleotides AC5 (AAGGCCTTCA TGGAGGTGGC CG) and
M13F-17 (GTAAAACGAC GGCCAGT) at 54°C, yielding a 2,143-bp fragment
(nt 1423 to 3566), which was subsequently digested with XhoI and XbaI, yielding
a 1,889-bp PCR-5xxN fragment (nt 1606 to 3495). The PCR-5xxN fragment was
subsequently used to replace the corresponding part of pHB-60 by using a rapid
DNA ligation kit and transformation of Escherichia coli cells. The DNA se-
quence of the selected plasmid clone of pHB60-s2VP3N was determined (nt
1600 to 3325). It appeared to have the intended mosaic D6948-TY89 cDNA
sequence, as shown in Fig. 1.
For the construction of pHB60-s2VP3C3, we first transferred a 1,735-bp frag-
ment of pHB36-s2VP3C into pHB-60 by using the unique SacII (nt 1670) and
XbaI (nt 3495) sites, yielding pHB60-s2VP3C1. The 3 untranslated region of
CEF94 was subsequently replaced by the corresponding cDNA sequence of
D6948. Fragment PCR-3UTR (385 bp, nt 3184 to 3566) was generated by using
primers AGTP (CTTGAGTGAG GTACCTGGGAG) and M13F-17 (GTAAA
ACGAC GGCCAGT), pHB-60 as the template, Pwo polymerase, and 20 reac-
tion cycles at a hybridization temperature of 52°C. This PCR-3UTR fragment
was purified and digested with KpnI and XbaI. The resulting fragment (315 bp,
nt 3198 to 3519) was gel purified and used to replace the corresponding part of
pHB60-s2VP3C1 (digested with KpnI and XbaI) by means of rapid ligation and
transformation of E. coli cells, yielding pHB60-s2VP3C2. Next, fragment
PCR-3N (1187 bp, nt 1423 to 2607) was generated by using oligonucleotides AC5
(AAGGCCTTCA TGGAGGTGGC CG) and vvVP3CM (GAGAAAATTT
CGCATCCGATG), pHB-60 as the template, Pwo polymerase, and 20 reaction
cycles at a hybridization temperature of 54°C. This PCR-3N fragment was puri-
fied (High Pure PCR purification; Boehringer Mannheim) and subsequently
digested with SacII (nt 1760) and ApoI (nt 2576). The resulting 816-bp fragment
was used to replace the corresponding part of pHB60-s2VP3C2 (digested with
ApoI [nt 2576] [partially] and SacII [nt 1760]), by means of rapid ligation and
transformation of E. coli cells, yielding pHB60-s2VP3C3. The DNA sequence of
the selected plasmid clone of pHB60-s2VP3C3 was determined (nt 1600 to
3275), and it appeared to have the intended mosaic D6948-TY89 cDNA se-
quence, as shown in Fig. 1.
Transfection of QM5 cells. QM5 cells were grown to 80% confluency in a
35-mm-diameter culture dish and infected with FP-T7 (multiplicity of infection
of 3). After 1 h, the cells were washed twice with 3 ml of QT-35 medium and
covered with 3 ml of Optimem 1 (Gibco/BRL). Meanwhile, DNA (1.0 g) was
mixed with 12.5 l of Lipofectamine (Gibco/BRL) in 250 l of Optimem 1 and
kept at room temperature for at least 30 min. Next, 2 ml of fresh Optimem 1 was
added to the QM5 cells, followed by the DNA-Lipofectamine mixture. Trans-
fection was performed overnight (18 h) in an incubator at 37°C (5.0% CO2). The
transfected monolayer was rinsed once with phosphate-buffered saline (PBS),
fresh QM5 medium (2.5 ml) was added, and the plates were further incubated
at the 37°C (5.0% CO2). After 24 h of incubation, the plates were freeze-thawed
once and the supernatant was filtered through a 200-nm-pore-size filter (Acro-
disc; Gelman Sciences) to remove fowlpox virus and cellular debris. If not
used immediately for further analysis, the cleared supernatant was stored at
70°C.
Western blotting. Monolayers of QM5 cells transfected with different full-
length A-segment plasmids (Table 1) were collected by scraping the surface of
the dish in the presence of 0.5 ml of PBS. Cells were collected by centrifugation
(5 min, 1,500  g) and resuspended in 0.2 ml of PBS supplemented with 20 mM
EDTA and 0.5 mg of leupeptin (Sigma) per ml. Cells lysates were prepared by
three cycles of freeze-thawing and centrifugation for 1 min at 13,000  g. The
supernatant (whole-cell lysate) was transferred to a clean tube and stored at
20°C. Samples of these lysates were separated in a sodium dodecyl sulfate
(SDS)–12% polyacrylamide gel and blotted onto nitrocellulose (Protean BA85;
Schleicher and Schuell). Detection of VP3 on the membrane was done by the
ECL detection method (Amersham) with VP3-specific MAb and peroxidase-
conjugated rabbit anti-mouse serum (Dako) as the secondary antibody.
Detection of infectious rIBDV. To detect the presence of recombinant IBDV
(rIBDV) after cotransfection of (modified) A and B segments, we inoculated a
96-well tissue culture plate containing a near-confluent monolayer of QM5 cells
with 10-fold dilutions of the cleared transfection supernatant. VP3 expression in
infected cells was visualized, after 48 h of incubation, in an immunoperoxidase
monolayer assay (IPMA) with MAb 9.7, a group-specific VP3 antibody (5).
Rescued IBDV (e.g., rD6948) with the inability to replicate on QM5 monolayers
was transferred to a monolayer of primary bursa cells grown in vitro for 24 h in
a 35-mm-diameter tissue culture dish in a CO2 incubator (5%) at 39°C. IBDV-
specific proteins in infected B-lymphoid cells were detected by using the IPMA
described above.
Virulence of the chimeric rIBDV strains. The virulence of the rIBDV strains
was evaluated in SPF layer-type chickens. Rescued IBDV was first propagated on
embryonated eggs by inoculating supernatant from a transfection experiment
into 11-day-old embryonated eggs via the chorioallantoic membrane route. After
five days of incubation, the embryos (dead or alive) were recovered, homoge-
nized in a Sorval Omni-mixer (three times for 10 s each at maximum speed),
clarified by centrifugation (6,000  g, 10 min), and subsequently stored in
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aliquots at 70°C. The virus titers (50% embryo lethal dose [ELD50]) in these
samples were determined with 11-day-old embryonated eggs.
In experiment 1, groups of chickens (21 days old, housed separately in isola-
tors) were administered, intranasally and intraocularly, 1,000 ELD50 of (r)IBDV
in PBS or only PBS (negative control group). The animals were monitored for
clinical signs daily, and dead chicks were removed and necropsied. In experiment
1 most birds were bled (5 ml) and euthanatized for necropsy at 9 days postin-
fection (p.i.), while some birds were left until day 15 p.i. to be bled and euthana-
FIG. 1. Schematic representation of the plasmids containing the full-length (hybrid) A-segment cDNA sequences. Although the T7 promoter
sequence, the hepatitis delta virus ribozyme (HDVR or HDR), and the T7 terminator are indicated only for plasmids pHB-36W and pHB-60, they
are present in each plasmid. Open boxes, CEF94 cDNA; shaded boxes, D6948 cDNA; dashed boxes, TY89 cDNA. UTR, untranslated region.
TABLE 1. Description of the viruses used
Virus Plasmid basis Main features Reference
CEF94 NRa Serotype I, classical, cell culture-adapted IBDV strain 5
D6948 NR Serotype I, vvIBDV field isolate 4
TY89 NR Prototype serotype II IBDV field isolate 25
rCEF94 pHB-36W  pHB-34Z Rescued CEF94; classical, cell culture-adapted IBDV 5
rD6948 pHB-60  pHB-55 Rescued D6948; vvIBDV 4
mCEF94-s2VP3 pHB36-s2VP3 pHB-34Z Rescued mIBDV having a hybrid polyprotein; amino acids 1–723 of CEF94 and
723–1012 of TY89
6
mCEF94-s2VP3N pHB36-s2VP3N  pHB-34Z Rescued mIBDV having a hybrid polyprotein; amino acids 1–723 and 857–1012 of
CEF94 and 723–856 of TY89
6
mCEF94-s2VP3C pHB36-s2VP3C  pHB-34Z Rescued mIBDV having a hybrid polyprotein; amino acids 1–856 of CEF94 and
857–1012 of TY89
6
mDT-VP3Nb pHB60-s2VP3N  pHB-55 mIBDV having a hybrid polyprotein; amino acids 1–723 and 857–1012 of D6948
and 723–856 of TY89
This work
mDCT-VP3C pHB60-s2VP3C1  pHB-55 Rescued mIBDV having a hybrid polyprotein; amino acids 1–543 of D6948 544–
856 of CEF94, and 857–1012 of TY89
This work
mDT-VP3C pHB60-s2VP3C3  pHB-55 Rescued mIBDV having a hybrid polyprotein; amino acids 1–856 of D6948 and
857–1012 of TY89
This work
a NR, not relevant.
b This virus could not be rescued.
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tized (see Table 3). In experiment 2, all birds were bled and euthanatized for
necropsy at day 13 p.i. Bursa and body weights were determined for all chicks
euthanatized.
Some samples from the bursa of Fabricius taken at necropsy were fixed in 10%
neutral buffered formalin for histopathology (experiments 1 and 2), and some
samples were snap frozen in liquid nitrogen and preserved at 70°C for immu-
nohistochemical examination (only experiment 1). Initial analyses of the bursa/
body weight ratios showed that standard deviations and means within groups
were approximately linearly related. Therefore, group effects were introduced on
the logarithmic scale and variances were assumed to be proportional to the
squares of the means. Effects were estimated by maximum-quasilikelihood esti-
mation. The dispersion variable (proportionality constant in the variance func-
tion) was estimated from Pearson’s chi-square statistics (26). Pairwise compari-
sons were based on approximate normality of estimated group effects on the log
scale. All calculations were performed with Genstat 5 (Genstat 5 release 3 refer-
ence manual, 1993; Nag Ltd., Oxford, United Kingdom), employing facilities for
generalized linear models (gamma distribution and logarithmic link function).
Virus neutralization assay. Serum samples from chickens in both animal
experiments were used to determine the amount of IBDV-neutralizing antibod-
ies. Diluted sera were incubated with 30 to 300 50% tissue culture infective doses
of IBDV strain CEF94 at 38°C with 5% CO2 for 1 h. After incubation, the
mixture was transferred to monolayers of QM5 cells in flat-bottom 96-well plates
(Greiner, Frickenhausen, Germany) and incubated for 24 h at 38°C with 5%
CO2. Thereafter the monolayers were washed with PBS, dried overnight, and
fixed in 4% paraformaldehyde for 10 min at 4°C. Infective centers were detected
in an IPMA using VP3-specific antibodies (see above).
Histopathology and immunohistochemistry. Formalin-fixed bursa samples
were dehydrated, embedded in paraffin wax, sectioned, and stained with hema-
toxylin-eosin. The histopathologic bursal lesion score (HBLS) was determined by
microscopic analysis of the bursa. The HBLS was determined on a scale of 1 to
5 as described by Bayyari et al. (2): 1, normal bursa; 2, scattered or partial follicle
damage; 3, 50% or less follicle damage; 4, 50 to 75% follicle damage; and 5, 75
to 100% follicle damage. Frozen bursa samples were sectioned for immunohis-
tology on a cryostat at 8-m thickness and taken up on glass slides (Superfrost).
The sections were fixed with acetone for 10 min, air dried, and stored at 20°C
until used. Immunoperoxidase staining was performed as described by Pol et al.
(30). Briefly, endogenous peroxidase in sections was eliminated by 0.01% H2O2.
Nonspecific reactions were blocked with 0.2% bovine serum albumin. MAb 9.7,
I/G4SI, IVSI, or VIIS2 was used as the primary antibody, a 1:100 dilution of rabbit
anti-mouse antibody conjugated to peroxidase (Dako) was used as the secondary
antibody, and diaminobenzidine was used as the substrate.
Genetic stability of the chimeric IBDV strain mDT-VP3C. To determine the
genetic stability of the mDT-VP3C strain, we inoculated 10 chickens (7 days old)
with 1,000 ELD50 each. At 3 days p.i. the bursas were recovered and pooled.
After addition of 3 volumes of tryptose phosphate broth (3%), the mixture was
homogenized in a Sorval Omni-mixer (3 times for 10 s each at maximum speed)
and subsequently clarified by centrifugation (6,000  g, 10 min.) and stored in
aliquots at70°C. The IBDV titer (ELD50) of the clarified bursa suspension was
determined on embryonated SPF eggs. This inoculation-extraction procedure
was repeated four times, each time using the recovered virus to start the next
round of infection (serial passages). After the first, third, and fifth round of
infection, viral dsRNA was extracted from the bursa homogenate by using a
QIAamp DNA minikit (Qiagen). Amplification of the 3 part of the A segment
was achieved by performing a reverse transcription step with primer ANC1 as
described before (7). The reverse-transcribed cDNA was used as the template in
a PCR with primers AGTM (GAGACTCCCA GGTACCTCACTC) and AC9
(CTCAAAGAAG ATGGAGACC). The PCR was performed with 10 pmol of
each primer, 2.5 mM MgCl2, 1 Taq buffer (Perkin-Elmer), 50 M each de-
oxynucleoside triphosphate, and 3 U of Taq polymerase (Perkin-Elmer) in a total
volume of 50 l. The amplification was performed by running 30 cycles through
temperature levels of 92°C (30 s), 58°C (30 s), and 72°C (50 s). The resulting PCR
fragment of 484 bp was agarose gel purified (High Pure purification kit; Boehr-
inger Mannheim) and used for direct sequence analysis in a cycle sequencing
reaction (BigDye terminator kit; PE Applied Biosystems) and an ABI310 appa-
ratus (PE Applied Biosystems).
RESULTS
Construction and analysis of chimeric A-segment plasmids.
To assess the viability, virulence, and antigenic properties of
IBDVs containing a chimeric A-segment dsRNA, we made
several full-length A-segment cDNA plasmids encoding a hy-
brid polyprotein (Fig. 1 and Table 1). Apart from A-segment
plasmids based upon CEF94 cDNA and encoding a VP3 that
is (partially) derived from the TY89 serotype 2 isolate, we also
constructed three chimeric plasmids that were based on the
A-segment plasmid of D6948, a very virulent serotype 1 IBDV
isolate. Two of these plasmids (pHB60-s2VP3C1 and -VP3C3)
encode a polyprotein in which the C-terminal part of VP3 is
derived from serotype 2, while the other (pHB60-s2VP3N)
encodes a polyprotein in which the N-terminal part of VP3
originates from serotype 2 IBDV. T7 RNA polymerase-driven
transcription of these plasmids results in positive-stranded A-
segment IBDV RNA which mimics the viral form of positive-
stranded RNA exactly, except for the absence of the viral
protein genome-linked molecule (VP1), which is most likely
present at the 5 end of the viral mRNA (15).
The plasmids were used to transfect cells of a quail fibroblast
cell line (QM5) that were infected with a recombinant fowlpox
virus expressing T7 RNA polymerase prior to transfection. No
replication of the resulting A-segment positive-stranded RNA
can occur in transfected cells because of the absence of RNA-
dependent RNA polymerase (VP1), which is encoded by the B
segment. After transfection, the cells were washed and total
cell extracts were assessed for the presence of (chimeric) VP3
by Western blot analysis (Fig. 2). Four different MAb known to
react with VP3 were used, and their reactivities are summa-
rized in Table 2. MAb B10A, an IBDV group-specific MAb,
reacted with VP3 originating from all of the plasmids used.
The serotype 1-specific MAb IVS1 reacted only with VP3 that
possessed the C-terminal part of serotype 1. The serotype
1-specific MAb I/G4S1 reacted only with the C-terminal part of
FIG. 2. Western blot analysis of protein samples isolated 24 h after
transfection from FP-T7-infected QM-5 cells transfected with pHB-
36W (lane 1), pHB36-s2VP3 (lane 2), pHB36-s2VP3N (lane 3),
pHB36-s2VP3C (lane 4), pHB-60 (lane 5), pHB60-s2VP3N (lane 6),
pHB60-s2VP3C1 (lane 7), or pHB60-s2VP3C3 (lane 8). Four SDS-
polyacrylamide gels containing equal amounts of cell extract were
blotted onto nitrocellulose, and VP3 was detected by using the four
indicated MAb. Sizes markers (Rainbow marker; Amersham) are in-
dicated in kilodaltons on the left.
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VP3 of the cell culture-adapted classical serotype 1 strain
(CEF94) and not with the corresponding part of the very vir-
ulent serotype 1 strain (D6948). The recognition pattern of the
serotype 2-specific MAb VIIS2 was the opposite of that of MAb
IVS1; it recognized only VP3 with the serotype 2 C-terminal
part. A small but distinct difference in migration of chimeric
VP3 due to the presence of the N-terminal part of serotype 2
VP3 was observed in the Western blot analysis. We always find
this difference in migration behavior of VP3 of the different
serotypes in SDS-polyacrylamide gel electrophoresis analysis
(6), despite the predicted molecular weights of VP3 of sero-
types 1 and 2 being the same. Most likely this difference in
migration behavior is due to a difference in the overall struc-
ture of the N-terminal part of VP3.
Amino acid sequence comparison. Based on the Western
blot analysis, we concluded that the VP3 epitopes that are
recognized by all four of the MAb used are most probably
linear. Furthermore, it is clear that the serotype-specific
epitopes of MAb IVS1, I/G4S1, and VIIS2 are present in the
C-terminal part (amino acids 850 to 1012) of VP3. An align-
ment of the deduced amino acid sequences of the VP3 part of
the polyprotein revealed differences between the two serotype
1 isolates CEF94 and D6948 (i.e., at amino acids 981 and 1005)
(Fig. 3). The fact that MAb I/G4S1 recognized only CEF94 and
not D6948 is probably because of one of these amino acid
differences. Furthermore, MAb I/G4S1 was also unable to in-
teract with the serotype 2-derived VP3, which has the same
amino acid mutation as D6948 at position 981 (L981P) (Fig. 3)
but lacks the mutation at position 1005. These data strongly
suggest that the epitope for I/G4S1 is located around position
981. The exact positions of the epitopes for IVS1 and VIS2 in
the C-terminal part of VP3 are presently unknown.
Rescue of infectious mIBDV. The full-length hybrid A-seg-
ment plasmids were transfected into FP-T7-infected QM5 cells
in combination with a full-length B-segment plasmid (cotrans-
fection). The presence of infectious mosaic IBDV (mIBDV)
24 h after transfection was shown by using either fresh QM5
cells (for rCEF94 and derivatives thereof) or primary bursa
cells (for rD6948 and derivatives thereof). We were unable to
detect infectious virus when plasmid pHB60-s2VP3N was
transfected in combination with plasmid pHB-55 containing
the full-length B segment of D6948. All rescued mIBDV and
parental wild-type strains were amplified on embryonated SPF
eggs, harvested from the infected embryos, and stored at
70°C.
Infection of SPF chickens with m IBDV. In an earlier study
we showed that mCEF94-s2VP3C had a slightly reduced re-
lease of progeny virus when grown on QM5 (6). We assessed
the virulence of this strain and the mIBDV strains rescued in
this study by inoculating (intranasally and intraocularly) groups
of SPF chickens with 1,000 ELD50 of wild-type or mIBDV
strains. Several virulence parameters during the living phase
and postmortem were determined (Table 3). In the first exper-
iment (experiment 1) we observed mortality during the first 5
days after inoculation only in those groups inoculated with
unmodified vvIBDV (D6948 or rD6849). No mortality oc-
curred in this experiment with the vvIBDV derivative mDCT-
VP3C. This was in contrast to the second experiment (exper-
iment 2), where one chicken (out of 15) died from an infection
FIG. 3. Comparison of the amino acid sequences of the C-terminal parts of the polyproteins of the classical, cell culture-adapted serotype 1
strain CEF94 (GenBank accession no. AF194428), the very virulent serotype 1 strain D6948 (AF240686), and the wild-type serotype 2 strain TY89
(AF312793). The amino acid sequence of the CEF94 polyprotein is presented, while only those amino acids that differ from the CEF94 sequence
are given for D6948 and TY89. The position of the ScaI restriction site (transition between the N- and C-terminal parts of the VP3) in the
corresponding cDNA (see Fig. 1) is indicated.
TABLE 2. Reactivities of the MAb with different virusesa
Virus Plasmid basis
Reactivity with MAb:
B10A IVS1 VIIS2 I/G4S1 9.7
CEF94 NRc     
D6948 NR     
TY89 NR     
rCEF94 pHB-36W  pHB-34Z     
rD6948 pHB-60  pHB-55     
mCEF94-s2VP3 pHB36-s2VP3  pHB-34Z     
mCEF94-s2VP3N pHB36-s2VP3N  pHB-34Z     
mCEF94-s2VP3C pHB36-s2VP3C  pHB-34Z     
mDT-VP3Nb pHB60-s2VP3N  pHB-55     
mDCT-VP3C pHB60-s2VP3C1  pHB-55     
mDT-VP3C pHB60-s2VP3C3  pHB-55     
a The data given are based upon the reactivity in a Western blot assay and/or
in an IPMA. No discrepancies were found between the reactivities of the same
MAb with these different techniques.
b This virus could not be rescued.
c NR, not relevant.
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with mDCT-VP3C. No mortality was induced in experiment 2
by mDT-VP3C, whereas we observed a high mortality rate for
both the wild-type and rescued D6948 (53 and 23%, respec-
tively). The bursa/body weight ratio of each surviving chicken
was determined after euthanization. This ratio is a good indi-
cation of the damage to the bursa caused by an IBDV infec-
tion. Cell culture-adapted IBDV strains (e.g., CEF94), which
do not specifically infect B-lymphoid cells in the bursa of Fab-
ricius, induced only a minor reduction of this ratio, while non-
cell culture-adapted IBDV strains (e.g., D6948), which specif-
ically infect the B-lymphoid cells of the bursa of Fabricius,
induced a large reduction of the bursa/body weight ratio (Ta-
ble 3). The introduction of the C-terminal part of the serotype
2 VP3 did not alter the ratio dramatically in experiment 1,
consistent with the fact that bursa tropism correlates with the
origin of VP2 (4). In experiment 2, the bursa/body weight ratio
with mDCT-VP3C differed significantly from that with the wild
type or rescued D6948. Whether this difference is specific to
this combination of D6948, CEF94, and TY89 cDNA se-
quences or is due to the intrinsic variation in animal experi-
ments (see also Discussion) is unclear.
Histopathology of infected bursas and presence of viral an-
tigen. Sections of the bursa of Fabricius of IBDV-infected
chickens (experiment 2) were examined after euthanization to
determine the severity of bursa damage. Bursa damage was
classified as described previously (2), where an HBLS of 1
indicates a normal bursa and an HBLS of 5 indicates 75 to
100% follicle damage (see Material and Methods). All viruses
containing VP2 of CEF94 induced only minor bursa damage
(2.0) (Table 3), while all viruses containing VP2 of D6948
induced severe bursa damage (4.7 to 5.0) (Table 3). Based
upon this HBLS, it would seem that not much difference in
bursa damage is present after infection with mDCT-VP3C,
mDT-VP3C or (r)D6948. However, careful examination re-
vealed some clear differences between the damage induced in
the bursa follicles by the different D6948-based viruses (Fig. 4).
Both D6948 and rD6948 completely destroyed the follicular
structure in the bursa and induced cystic formation, while the
follicular structure of the bursas of mDT-VP3C-infected chick-
ens was still present. Although some bursa follicles of mDT-
VP3C-infected chickens have the same appearance as those
found in bursas of mock-infected chickens, the diameter of
these follicles is smaller than that of the wild-type follicles. The
differences between bursas infected with D6948 and mDT-
VP3C are also clear from the detection of viral antigen (Table
4). No viral antigen was detected in an VP2-based enzyme-
linked immunosorbent assay (ELISA) at 9 days p.i. of mDT-
VP3C, while a large amount of viral VP2 was present in bursas
of chickens infected with D6948 (Table 4). There was also a
clear difference in the presence of IBDV infectious particles
(about a 100-fold reduction of the ELD50) between chickens
infected with mDT-VP3C (titer of 2.6) and with D6948 (titer of
6.0) (Table 4).
Immunohistochemistry of infected bursas. Sections of the
bursa of Fabricius of IBDV-infected chickens (experiment 1)
were examined for the presence of viral antigen after infection.
MAb, either group specific (MAb 9.7) or serotype specific
(MAb IVS1, I/G4S1, or VIIS2), were used to detect the distri-
bution of viral antigen throughout the infected bursa and to
assess the usefulness of the C-terminal part of the serotype 2
VP3 as an immunological marker. VP3 was detected in all
three examined bursas of chickens infected with rD6948 or
mDCT-VP3C when group-specific MAb 9.7 was used. As ex-
pected, we did not detect any viral antigen when MAb IVS1 was
used after infection with mDCT-VP3C and when MAb VIIS2
was used with sections of rD6948-infected bursas (Fig. 5).
Consistent with the results of the Western blot analysis, we
found no reaction of MAb I/G4 with sections of bursas infected
with either rD6948 or mDCT-VP3C.
Determination of the nucleotide sequence of mDT-VP3C
after infection. To determine the genetic stability of mDT-
VP3C after infection of SPF chickens, we inoculated chickens
with this recombinant virus five times sequentially. Viral
dsRNA was isolated at 3 days p.i. from the bursas of the
infected chickens after the first, third, and fifth sequential
passages. Following reverse transcription-PCR amplification,
TABLE 3. Experimental data from the chicken infection experiments
Expt and virus Mortalitya Virus neutralizationtiterb (SD)
Avg bursa wt, g
(SD, no. of animals)
Avg bursa/body wt
ratio (SD), 103
Avg HBLSc
(SD, no. of bursas scored)
1
None (PBS) 0/10 0.0 (0.0) 1.9 (0.4, 10) 6.1 (1.2) 1.0 (0.0, 9)
CEF94 0/10 2.7 (3.1) 2.0 (0.6, 6) 6.0 (1.8) 1.6 (1.1, 10)
rCEF94 0/10 9.7 (1.8) 1.3 (0.5, 6) 4.2 (1.3) 1.9 (0.7, 10)
mCEF94-s2VP3C 0/10 10.8 (1.5) 1.3 (0.4, 6) 4.1 (1.3) 1.1 (0.3, 10)
D6948 3/10 10.3 (1.4) 0.4 (0.1, 7) 1.7 (0.6) 5.0 (0.0, 7)
rD6948 5/10 10.3 (1.5) 0.4 (0.1, 5) 1.7 (0.2) 5.0 (0.0, 4)
mDCT-VP3C 0/10 10.8 (1.2) 0.6 (0.2, 6) 1.9 (0.6) 5.0 (0.0, 8)
2
None (PBS) 0/15 0.0 (0.0) 2.3 (0.7, 15) 6.1 (1.8) 1.4 (1.3, 10)
D6948 8/15 11.7 (1.6) 0.3 (0.2, 7) 0.8 (0.7) 5.0 (0.0, 8)
rD6948 7/30 10.0 (1.5) 0.3 (0.1, 23) 1.0 (0.4) 5.0 (0.0, 20)
mDCT-VP3C 1/15 9.0 (1.8) 0.9 (0.2, 14) 2.7 (0.7)d 4.7 (0.7, 10)
mDT-VP3C 0/15 8.8 (1.6) 0.5 (0.1, 15) 1.6 (0.4) 5.0 (0.0, 10)
a Accumulated number of deaths during the first 5 days p.i/total number of infected birds
b The presence of neutralizing antibodies was determined by using CEF94; titers are given as log2 values.
c Of birds that survived the infection.
d The bursa/body weight ratio of this group differs significantly from those of all other groups in experiment 2 (P  0.001 on all occasions).
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we directly sequenced the region of the A segment of mDT-
VP3C corresponding to the complete genomic dsRNA region
originating from the serotype 2 strain TY89. Sequence align-
ment of the mDT-VP3C-produced reverse transcription-PCR
fragments with the original cDNA plasmid pHB60-s2VP3C3
revealed that no nucleotide mutations were present in the
genome of mDT-VP3C after the sequential passages.
DISCUSSION
Outbreaks of vvIBDV pose a continuing threat to the poul-
try industry worldwide. Live vaccines currently in use to pre-
vent vvIBDV outbreaks are based on adapted field isolates of
vvIBDV, the molecular basis of which is unknown. Moreover,
the residual virulence of these so-called hot vaccine strains is
still considerably high, hampering official registration and lead-
ing to uncontrolled usage of wild-type vvIBDV strains as hot
vaccines during an outbreak. Our search for a new live vvIBDV
vaccine with limited residual virulence that would also serve as
an immunological marker for differentiation between the vac-
cine and field strains culminated in our obtaining the first
engineered recombinant vvIBDV strain to possess both prop-
erties. The rescued mosaic vvIBDV described in this paper
encodes a VP3 that is based partly upon the serotype 1 genome
and partly upon the serotype 2 genome. Introduction of the
VP3 sequence of serotype 2 results in attenuation, as is clear
from a large reduction or even absence of mortality in highly
susceptible SPF chickens as well as a reduction in bursa dam-
age. Furthermore, by using specific MAb in an immunohisto-
chemical analysis, we have proved that we can distinguish be-
tween bursas infected with wild-type (r)IBDV and bursas
infected with the engineered mIBDV.
Amino acid sequence comparison of IBDV serotype 1 and 2
strains reveals that the hypervariable region of VP2 (amino
acids 224 to 314; identity of less than 70%) is the most diverse.
This hypervariable region is involved both in receptor recog-
nition and in binding of neutralizing antibodies. Sequence
identity in the other parts of the polyprotein (i.e., the remain-
ing parts of VP2, VP4, and VP3) is above 90%. The identity
between VP3 of serotype 1 and 2 is 96%, and four mutations
are clustered in the first 33 amino acids of VP3 (Fig. 3). We
failed to rescue mosaic vvIBDV containing these four muta-
tions and one additional mutation located more downstream
(mDT-VP3N [Table 1]). This failure might have been due to
the inviability of the engineered virus or to the inefficient
rescue of severely crippled mosaic vvIBDV.
Although we believe that our cDNA transfection method is
more efficient than the mRNA transfection method (3), we
FIG. 4. Representative hematoxylin-eosin-stained sections of the bursa of Fabricius recovered at day 13 p.i. of SPF chickens either mock
infected or infected with wild-type vvIBDV D6948 or mDT-VP3C (experiment 2). The HBLS (2) was determined for at least eight birds infected
with the same virus (see Table 3).
TABLE 4. Presence of virus in the bursas of SPF chickens
at 9 days p.i. (experiment 1)
Virus Viral antigen (SD)a Viral titer (SD)b
None (PBS) 97 (22)
D6948 2,738 (251) 6.0 (0.8)
mDT-VP3C 104 (9) 2.6 (2.0)
a The amount of viral antigen (A450) in each bursa homogenate (n  4) was
determined by using a VP2-specific ELISA.
b The viral titer (ELD50) in bursa homogenates of chickens (n  4) was
determined on embryonated SPF eggs.
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also tried to rescue virus from pHB60-s2VP3N after cotrans-
fection of capped mRNA. However, several independent co-
transfection experiments with mRNAs derived from pHB60-
s2VP3N and pHB-55 did not result in infectious mDT-VP3N
(data not shown). The fact that SDS-polyacrylamide gel elec-
trophoresis migration of chimeric VP3 proteins alters when the
serotype 2 N-terminal part is present (Fig. 2) indicates that the
overall properties of this hybrid VP3 are different from those
of wild-type serotype 1 VP3. Furthermore, we discovered that
both the rescue efficiency and final titers of the corresponding
cell culture-adapted variant of this virus (mCEF94-s2VP3N)
were considerably less than those of the wild-type virus (6).
The rescued IBDV strains were analyzed in two different
animal experiments with essentially the same experimental
setup. Postmortem analysis of the bursa of Fabricius of in-
fected chickens indicated persistent bursa tropism of mosaic
vvIBDV viruses, as the bursa/body weight ratio was consider-
ably less than that for the noninfected chickens or (m)CEF94-
infected chickens. Despite the bursa tropism, no mortality was
induced by infection with mDCT-VP3C in experiment 1. How-
ever, in experiment 2 one chick died, indicating some residual
pathogenicity. The other mosaic vvIBDV tested in experiment
2 (mDT-VP3C) did not induce mortality. This result was un-
expected, as mDT-VP3C resembles wild-type D6948 more
than mDCT-VP3C does (Fig. 1 and Table 1). We believe that
the mDCT-VP3C-induced mortality in experiment 2 and not in
experiment 1 is because of the variation that is intrinsic in
animal trials. Variation was also observed between the two
different animal trials with wild-type and rescued D6948 virus
infections. The virus preparations used to inoculate the SPF
chickens in animal experiments 1 and 2 had exactly the same
history (only the storage time at 70°C was different) and the
same formulation (diluted in PBS). Despite this, we found
considerable variation in mortality during the first days after
infection (30 and 53% for D6948 and 50 and 23% for rD6948
in experiments 1 and 2, respectively). This variation made it
difficult for us to use differences in mortality rates in SPF
chickens as a parameter for the exact classification of the
virulence of (modified) vvIBDV strains.
The ratio between the weight of the bursa of Fabricius and
the weight of the body (bursa/body weight ratio) is an objective
and commonly used way of measuring IBDV pathogenicity. In
our two animal experiments, the bursa/body weight ratio gives
a clear-cut difference between viruses that possess B-lymphoid
cell tropism (i.e., D6948-derived viruses [bursa/body weight
ratio,3.0]) and those that do not (i.e., CEF94-derived viruses
[bursa/body weight ratio, 3.0]). Variation between the two
animal experiments was found in the case of mDCT-VP3C (the
bursa/body weight ratios were 1.9 [standard deviation, 0.6] and
2.7 [standard deviation, 0.7]) in experiments 1 and 2, respec-
tively). The slightly different experimental setups in experi-
ment 1 (the bursa/body weight ratio was determined at 9 days
p.i.) and experiment 2 (the bursa/body weight ratio was deter-
mined at 13 days p.i.) and the repopulation of the partly dam-
aged bursa by new B-lymphoid cells might be the reason for the
different bursa/body weight ratios. Although repopulation is an
important criterion after clearance of the IBDV infection, 14
days p.i. would be very early for a considerable repopulation to
occur.
Determination of the histological damage of the bursa of
Fabricius after infection is another way of measuring the vir-
ulence of IBDV strains. Using the classification developed
previously (2), we found no difference between the severe
damage induced by infection with vvIBDV (D6948 and
rD6948) and the modified derivatives (mDCT-VP3C and
mDT-VP3C). The method used to measure the level of dam-
age in IBDV-infected bursas is not standardized. The overall
damage is influenced by the reduction in percentage of B-
lymphoid cells per follicle, the number of completely depopu-
lated follicles, and the amount of necrosis and cystic formation.
Furthermore, the lack of repopulation of the depleted follicles
with new B-lymphoid cells seems to be the most important
factor accounting for the observed subclinical immunosuppres-
sion associated with an IBDV infection. Thus, despite the
equal HBLS values for wild-type IBDV and mIBDV, we found
a clear difference between the induced bursa damage after
infection with mIBDV and infection with unmodified vvIBDV
(Fig. 4). Whether there is a difference in subclinical immuno-
suppression between the wild-type vvIBDV and the mIBDV
strains will need to be evaluated in additional animal experi-
ments, for instance, by challenge of IBDV-vaccinated SPF
chickens with Newcastle disease virus and measurement of the
neutralizing antibody response.
FIG. 5. Viral antigen detection in bursas recovered 9 days after
infection of SPF chickens with either rD6948 or mDCT-VP3C (exper-
iment 1). MAb for VP3 known to react group specifically (MAb 9.7) or
serotype specifically (MAb IVSI, I/G4SI, and VIIS2) were used as pri-
mary antibodies on acetone-fixed cryostat slices.
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The present lack of objective virulence parameters for IBDV
makes it difficult to quantify residual virulence of modified
vvIBDV strains. An objective and quantitative classification of
the virulence of recombinant IBDV strains will become in-
creasingly more important as more genetically altered vvIBDV
strains become available.
Despite the fact that the wild-type vvIBDV strain D6948 and
the mosaic vvIBDV strain mDT-VP3C differ by only a mere six
amino acids, mDT-VP3C was found to be clearly less virulent.
VP3 has interactions at least with itself (trimer formation) and
with two other viral proteins (i.e., VP2, and VP1). The direct
interaction between VP3 and VP1 (and VPg) has been shown
indirectly by analysis in the yeast two-hybrid system (32) and
directly by specific immunoprecipitations (24, 32). The inter-
action of the trimeric VP3 with the trimeric VP2 at the inter-
face of the outer capsid layer (VP2) and inner capsid layer
(VP3) has been shown by electron cryomicroscopy (8, 11).
Mutations in the C-terminal part of VP3 might thus influence
one or multiple protein-protein interactions.
VP3 is also postulated to interact with the viral genome. The
basic amino acids in the C-terminal part of VP3 are the prime
candidates for this interaction (8, 19). Recently, we showed
that VP3 is indeed able to interact with the viral dsRNA (32a).
The fact that the capsid protein VP3 interacts with two essen-
tial components of the genome replication machinery (i.e., the
dsRNA and the RNA-dependent RNA polymerase [VP1])
suggests that VP3 has a multifunctional role in replication of
the dsRNA. The three-dimensional structure of VP3 of birna-
viruses is not yet known, making it difficult to allocate the
different homotypic or heterotypic protein- and dsRNA-inter-
acting domains to specific positions on VP3 and to predict the
effect of amino acid mutations in the C-terminal part on VP3
on these interactions.
Despite replication of mDT-VP3C being somewhat im-
paired in comparison to that of wild-type virus, no major se-
lection pressure on the introduced part of the serotype 2 ge-
nome of the chimeric mDT-VP3C3 seemed to be present.
Sequential passage of this virus (five times) did not lead to any
back mutation of the introduced nucleotide changes.
Immunohistological examination shows that specific MAb
can be used to differentiate between bursas infected with wild-
type vvIBDV and bursas infected with our engineered mIBDV
and vice versa. A proven approach to distinguish between
wild-type-(vv)IBDV-infected chickens and vaccinated chickens
is to make use of a difference in the antibody response after
vaccination and infection. We are currently developing an in-
direct competition ELISA to evaluate whether the different
antigenic structure of mDT-VP3C indeed induces an antibody
response that can be differentiated from that of wild-type-
(vv)IBDV-infected chickens.
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